Clinical Trial Update: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma [Phase 2]

View source ↗

Summary

A Phase 2 randomized international trial in malignant progressive pheochromocytoma and paraganglioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL) | Phase 2 | Status: COMPLETED